Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The HIV Vaccine Trials Network (HVTN) Laboratory Program is part of an international collaboration of scientists and educators searching for an effective and safe HIV vaccine. The HVTN’s mission is to facilitate the process of testing preventive vaccines against HIV/AIDS. The organization conducts all phases of clinical trials from evaluating experimental vaccines for safety and the ability to stimulate immune responses to testing vaccine efficacy. The Laboratory Program is responsible for carrying out the scientific agenda of the HVTN in determining by laboratory based studies which vaccine regimens should be advanced for efficacy trials and show promise for licensure. This effort includes leading a number of working groups, committees, specimen repository oversight, assay performance and quality assurance.
The Laboratory Protocol Coordinator will coordinate and support the laboratory studies for the HIV Vaccine Trials Network (HVTN) protocols (clinical trials). The incumbent works under the direction of the Laboratory Protocol Operations Manager. The Laboratory Protocol Coordinator will participate in HVTN conference calls and meetings, prepare written reports and oral presentations, and as necessary, assist with grant applications. S/he will coordinate with Statistical Center for HIV/AIDS Research and Prevention (SCHARP), protocol teams, clinical trial sites and study sponsors on protocol operations, data transfer, analysis and presentations.